Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Prestige Consumer Healthcare Inc.PBH · Entity 4350 | Director | August 04, 2020 | August 06, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Prestige Consumer Healthcare Inc.
Report date August 04, 2020 · Filed August 06, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 50,200 |
Reported balance
After 2020-08-04 transaction · row 1
1 source rowRow 1 · 2020-08-04 · Grant · Acquired 3,732 · Balance 50,200 F1: The Reporting Person received 3,732 restricted stock units (equal to $145,000 divided by the closing stock price of $38.86 on August 4, 2020) in connection with the Issuer's director compensation program. The restricted stock units vest immediately upon grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person received 3,732 restricted stock units (equal to $145,000 divided by the closing stock price of $38.86 on August 4, 2020) in connection with the Issuer's director compensation program. The restricted stock units vest immediately upon grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TIFFANY & CO
Report date May 24, 2018 · Filed June 04, 2018
Section 16 reporting ended · disclosed 2018-06-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock $.01 ParSEC Table I · non-derivative | Direct | 10,962 |
Reported balance
Holding disclosure · report date 2018-05-24 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 10,962 F1: 9,029 shares in the total are vested restricted stock units. The reporting person has elected to defer the maturity date of the vested restricted stock units (and thereby the delivery of the related shares) until six months after the date on which he ceased to be a director. |
Filing footnotes · ownership attribution and instrument terms
F1: 9,029 shares in the total are vested restricted stock units. The reporting person has elected to defer the maturity date of the vested restricted stock units (and thereby the delivery of the related shares) until six months after the date on which he ceased to be a director.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 04, 2020 Filed Aug 6, 2020 21:24 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 3,732 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-091551 · tm2023357d7_4.xml · nonDerivative · entry 1 COSTLEY GARY E · CIK 0001202277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,200 F1 · shares: The Reporting Person received 3,732 restricted stock units (equal to $145,000 divided by the closing stock price of $38.86 on August 4, 2020) in connection with the Issuer's director compensation program. The restricted stock units vest immediately upon grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control. Read SEC document |
| July 30, 2019 Filed Aug 1, 2019 20:24 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 4,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-037209 · tv526531_4.xml · nonDerivative · entry 1 COSTLEY GARY E · CIK 0001202277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,468 F1 · shares: The Reporting Person received 4,183 restricted stock units (equal to $145,000 divided by the closing stock price of $34.67 on July 30, 2019) in connection with the Issuer's director compensation program. The restricted stock units vest immediately upon grant and will be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of (i) the Reporting Person's death, (ii) the Reporting Person's separation from service or (iii) change in control. Read SEC document |
| July 31, 2018 Filed Aug 1, 2018 20:01 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 3,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-041351 · tv499904_4.xml · nonDerivative · entry 1 COSTLEY GARY E · CIK 0001202277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,285 F1 · shares: The Reporting Person received 3,779 restricted stock units (equal to $135,000 divided by the closing stock price of $35.73 on July 31, 2018) in connection with the Issuer's director compensation arrangement. The restricted stock units vest immediately upon execution and acceptance of the award and shall be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of the Reporting Person's (i) death, (ii) disability or (iii) the six-month anniversary of the date on which the Reporting Person's Board membership ceases for reasons other than death or disability. Read SEC document |
| February 05, 2018 Filed Feb 5, 2018 21:04 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | PurchaseCommon Stock, par value $0.01 per share | 7,500 | $35.47 | $266,025.00 |
DisclosureSEC source: 0001144204-18-005698 · tv484888_form4.xml · nonDerivative · entry 1 COSTLEY GARY E · CIK 0001202277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,506 Read SEC document |
| January 24, 2018 Filed Jan 25, 2018 17:17 UTC | TIFFANY & CO TIF · Entity 143953 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,878 | $0.00 Strike: $61.12 | $0.00 |
DisclosureSEC source: 0000098246-18-000100 · wf-form4_151691864770980.xml · derivative · entry 7 COSTLEY GARY E · CIK 0001202277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock $.01 Par · 2,878 shares Expires 2022-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Granted Pursuant to the Tiffany & Co. 2008 Directors Equity Compensation Plan, which complies with Rule 16(b)-3, on May 17, 2012. The option vested in full on the grant date. F8 · balance_after: Total grant 2,878 shares. 0 shares previously exercised. Read SEC document |
| January 24, 2018 Filed Jan 25, 2018 17:17 UTC | TIFFANY & CO TIF · Entity 143953 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 2,477 | $0.00 Strike: $70.28 | $0.00 |
DisclosureSEC source: 0000098246-18-000100 · wf-form4_151691864770980.xml · derivative · entry 6 COSTLEY GARY E · CIK 0001202277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock $.01 Par · 2,477 shares Expires 2021-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Options granted pursuant to the Tiffany & Co. 2008 Directors Equity Compensation Plan, which complies with Rule 16b-3, on May 19, 2011. The option vested in full on the grant date. F6 · balance_after: Total grant 2,477 shares. 0 shares previously exercised. Read SEC document |
| January 24, 2018 Filed Jan 25, 2018 17:17 UTC | TIFFANY & CO TIF · Entity 143953 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 3,860 | $0.00 Strike: $42.37 | $0.00 |
DisclosureSEC source: 0000098246-18-000100 · wf-form4_151691864770980.xml · derivative · entry 5 COSTLEY GARY E · CIK 0001202277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock $.01 Par · 3,860 shares Expires 2020-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options granted pursuant to the Tiffany & Co. 2008 Directors Equity Compensation Plan, which complies with Rule 16b-3, on May 20, 2010. The option vested in full on the first business day following the grant date. F4 · balance_after: Total grant 3,860 shares. 0 shares previously exercised. Read SEC document |
| January 24, 2018 Filed Jan 25, 2018 17:17 UTC | TIFFANY & CO TIF · Entity 143953 | SaleCommon Stock $.01 Par | 9,215 | $109.33 | $1,007,480.56 |
DisclosureSEC source: 0000098246-18-000100 · wf-form4_151691864770980.xml · nonDerivative · entry 4 COSTLEY GARY E · CIK 0001202277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,962 F2 · price: The price in Column 4 is a weighted average price. The price actually received ranged from $109.3301 to $109.3400 per share. The reporting person's broker has provided to the issuer and the issuer will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F1 · balance_after: Includes 9,962 restricted stock units, 9,029 of which are vested and 933 of which will vest on the earlier of May 25, 2018, or the termination of the reporting person's service as a director due to death or disability. Read SEC document |
| January 24, 2018 Filed Jan 25, 2018 17:17 UTC | TIFFANY & CO TIF · Entity 143953 | Exercise / conversionCommon Stock $.01 Par | 2,878 | $61.12 | $175,903.36 |
DisclosureSEC source: 0000098246-18-000100 · wf-form4_151691864770980.xml · nonDerivative · entry 3 COSTLEY GARY E · CIK 0001202277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 9,962 restricted stock units, 9,029 of which are vested and 933 of which will vest on the earlier of May 25, 2018, or the termination of the reporting person's service as a director due to death or disability. Read SEC document |
| January 24, 2018 Filed Jan 25, 2018 17:17 UTC | TIFFANY & CO TIF · Entity 143953 | Exercise / conversionCommon Stock $.01 Par | 2,477 | $70.28 | $174,083.56 |
DisclosureSEC source: 0000098246-18-000100 · wf-form4_151691864770980.xml · nonDerivative · entry 2 COSTLEY GARY E · CIK 0001202277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 9,962 restricted stock units, 9,029 of which are vested and 933 of which will vest on the earlier of May 25, 2018, or the termination of the reporting person's service as a director due to death or disability. Read SEC document |
| January 24, 2018 Filed Jan 25, 2018 17:17 UTC | TIFFANY & CO TIF · Entity 143953 | Exercise / conversionCommon Stock $.01 Par | 3,860 | $42.37 | $163,548.20 |
DisclosureSEC source: 0000098246-18-000100 · wf-form4_151691864770980.xml · nonDerivative · entry 1 COSTLEY GARY E · CIK 0001202277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 9,962 restricted stock units, 9,029 of which are vested and 933 of which will vest on the earlier of May 25, 2018, or the termination of the reporting person's service as a director due to death or disability. Read SEC document |
| January 10, 2018 Filed Jan 12, 2018 18:25 UTC | TIFFANY & CO TIF · Entity 143953 | GrantDividend Equivalent Units · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0000098246-18-000049 · wf-form4_151579950498829.xml · derivative · entry 2 COSTLEY GARY E · CIK 0001202277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18 Underlying: Common Stock $.01 Par · 5 shares Expires not disclosed F2 · security: Registrant's transfer agent maintains a direct stock purchase program for Registrant's stockholders with a dividend reinvestment feature. Accordingly, pursuant to Rule 16a-11, dividend equivalent units will no longer be reported on a Form 4 at the time of accrual. F3 · derivative.exercise_price: Represents dividend equivalent units accrued on January 10, 2018 in respect of vested restricted stock units granted to the reporting person on May 26, 2016 pursuant to the Tiffany & Co. 2008 Directors Equity Compensation Plan, which complies with Rule 16b-3. The dividend equivalent units convert to the issuer's common stock on a one-for-one basis. F4 · derivative.exercise_date: The dividend equivalent units vest proportionately with the underlying restricted stock units to which they relate. The reporting person has elected to defer the maturity date of all the restricted stock units and the related dividend equivalent units (and thereby the delivery of the related shares) until six months after the date on which he ceases to be a director. The terms of the restricted stock units provide for earlier delivery upon the death, or the end of service as a result of the disability, of the reporting person. F4 · derivative.expiration_date: The dividend equivalent units vest proportionately with the underlying restricted stock units to which they relate. The reporting person has elected to defer the maturity date of all the restricted stock units and the related dividend equivalent units (and thereby the delivery of the related shares) until six months after the date on which he ceases to be a director. The terms of the restricted stock units provide for earlier delivery upon the death, or the end of service as a result of the disability, of the reporting person. Read SEC document |
| October 10, 2017 Filed Oct 13, 2017 16:36 UTC | TIFFANY & CO TIF · Entity 143953 | GrantDividend Equivalent Units · Derivative | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0000098246-17-000271 · wf-form4_150792698008556.xml · derivative · entry 2 COSTLEY GARY E · CIK 0001202277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12 Underlying: Common Stock $.01 Par · 6 shares Expires not disclosed F2 · derivative.exercise_price: Represents dividend equivalent units accrued on October 10, 2017 in respect of vested restricted stock units granted to the reporting person on May 26, 2016 pursuant to the Tiffany & Co. 2008 Directors Equity Compensation Plan, which complies with Rule 16b-3. The dividend equivalent units convert to the issuer's common stock on a one-for-one basis. F3 · derivative.exercise_date: The dividend equivalent units vest proportionately with the underlying restricted stock units to which they relate. The reporting person has elected to defer the maturity date of all the restricted stock units and the related dividend equivalent units (and thereby the delivery of the related shares) until six months after the date on which he ceases to be a director. The terms of the restricted stock units provide for earlier delivery upon the death, or the end of service as a result of the disability, of the reporting person. F3 · derivative.expiration_date: The dividend equivalent units vest proportionately with the underlying restricted stock units to which they relate. The reporting person has elected to defer the maturity date of all the restricted stock units and the related dividend equivalent units (and thereby the delivery of the related shares) until six months after the date on which he ceases to be a director. The terms of the restricted stock units provide for earlier delivery upon the death, or the end of service as a result of the disability, of the reporting person. Read SEC document |
| August 01, 2017 Filed Aug 3, 2017 19:30 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-040281 · v472274_4.xml · nonDerivative · entry 1 COSTLEY GARY E · CIK 0001202277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,006 F1 · shares: The Reporting Person received 2,564 restricted stock units (equal to $135,000 divided by the closing stock price of $52.64 on August 1, 2017) in connection with the Issuer's director compensation arrangement. The restricted stock units vest immediately upon execution and acceptance of the award and shall be settled by delivery to the Reporting Person of one share of common stock of the Issuer for each vested restricted stock unit promptly following the earliest of the Reporting Person's (i) death, (ii) disability or (iii) the six-month anniversary of the date on which the Reporting Person's Board membership ceases for reasons other than death or disability. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 17:19 UTC | TIFFANY & CO TIF · Entity 143953 | GrantDividend Equivalent Units · Derivative | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0000098246-17-000187 · wf-form4_149989435111228.xml · derivative · entry 2 COSTLEY GARY E · CIK 0001202277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6 Underlying: Common Stock · 6 shares Expires not disclosed F2 · derivative.exercise_price: Represents dividend equivalent units accrued on July 10, 2017 in respect of vested restricted stock units granted to the reporting person on May 26, 2016 pursuant to the Tiffany & Co. 2008 Directors Equity Compensation Plan, which complies with Rule 16b-3. The dividend equivalent units convert to the issuer's common stock on a one-for-one basis. F3 · derivative.exercise_date: The dividend equivalent units vest proportionately with the underlying restricted stock units to which they relate. The reporting person has elected to defer the maturity date of all the restricted stock units and the related dividend equivalent units (and thereby the delivery of the related shares) until six months after the date on which he ceases to be a director. The terms of the restricted stock units provide for earlier delivery upon the death, or the end of service as a result of the disability, of the reporting person. F3 · derivative.expiration_date: The dividend equivalent units vest proportionately with the underlying restricted stock units to which they relate. The reporting person has elected to defer the maturity date of all the restricted stock units and the related dividend equivalent units (and thereby the delivery of the related shares) until six months after the date on which he ceases to be a director. The terms of the restricted stock units provide for earlier delivery upon the death, or the end of service as a result of the disability, of the reporting person. Read SEC document |
| May 25, 2017 Filed May 30, 2017 18:21 UTC | TIFFANY & CO TIF · Entity 143953 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 5,450 | $0.00 Strike: $85.82 | $0.00 |
DisclosureSEC source: 0000098246-17-000141 · wf-form4_149618289039690.xml · derivative · entry 2 COSTLEY GARY E · CIK 0001202277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,450 Underlying: Common Stock $.01 Par · 5,450 shares Expires 2027-05-25 F4 · derivative.exercise_date: Options granted pursuant to the Tiffany & Co. 2008 Directors Equity Compensation Plan, which complies with Rule 16b-3. The option is exercisable on the first business day following the grant date. Read SEC document |
| May 25, 2017 Filed May 30, 2017 18:21 UTC | TIFFANY & CO TIF · Entity 143953 | GrantCommon Stock $.01 Par | 933 | $0.00 | $0.00 |
DisclosureSEC source: 0000098246-17-000141 · wf-form4_149618289039690.xml · nonDerivative · entry 1 COSTLEY GARY E · CIK 0001202277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,962 F1 · shares: Includes 933 unvested restricted stock units, which will vest in accordance with their terms on the earlier of the one-year anniversary of the grant date, or the termination of the reporting person's service as a director due to death or disability. F2 · price: Given for no consideration. F3 · balance_after: Includes 9,962 restricted stock units, 9,029 of which are vested and 933 of which will vest on the earlier of May 25, 2018, or the termination of the reporting person's service as a director due to death or disability. The reporting person has elected to defer the maturity date of the 9,029 vested restricted stock units (and thereby the delivery of the related shares) until six months after the date on which he ceases to be a director. The terms of the restricted stock units provide for earlier delivery upon the death, or the end of service as a result of the disability, of the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.